People
Columbia, SC – Obsidio, Inc., a pre-clinical stage medical materials developer pioneering a universal embolic hydrogel designed to be delivered minimally invasively through a clinical catheter for blood vessel occlusion, announced the formation of its clinical advisory board.
Here are five high-quality examples of major bio organizations’ efforts to showcase their commitment to providing a positive D&I work environment.
Panthera Biopartners has strengthened its management team with the appointment of Jane Restorick as Chief Commercial Officer.
Pharma and life science companies strengthen their leadership teams and boards of directors with this week’s appointments.
Bio Buzz selected five women venture capitalists who are considered “trailblazing investors shaping the future of life science investing” in the BioCapital Hotbed Community, which includes Delaware, Maryland, Virginia and Washington, D.C.
The government said Petit and former Chief Operating Officer William Taylor engaged in a scheme to “fraudulently inflate” the revenue of MiMedx.
Dr. Singh is renowned for her expertise in molecular science, clinical management and national health policy
La Jolla Pharmaceutical Company, a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, announced that George Tidmarsh, M.D., Ph.D., President and Chief Executive Officer, has left the Company to pursue other interests.
Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, announced the appointment of Jonathan Biller to the newly created role of chief legal officer effective December 3, 2019.
H.E.L. Group announced the strengthening of the Company’s senior management team with Paul Orange, Ph.D. joining as Chief Marketing Officer, and Paul Sturgeon as Chief Financial Officer.
PRESS RELEASES